Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Apr 1;179(4):1367-71.
doi: 10.1084/jem.179.4.1367.

CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major

Affiliations

CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major

Z E Wang et al. J Exp Med. .

Abstract

Mice with homologous disruption of the interferon gamma (IFN-gamma) gene on the C57BL/6 background were infected with Leishmania major and the immune response assessed. In contrast to wild-type or heterozygous knockout mice, deficient animals were unable to restrict growth of the parasite and suffered lethal infection over 6-8 wk. Although wild-type and heterozygous littermates developed CD4+ cells that contained transcripts for IFN-gamma and lymphotoxin, typical of T helper type 1 (Th1) cells, the knockout mice developed CD4+ cells that contained transcripts for interleukin 4 (IL-4), IL-5, and IL-13, typical of Th2 cells. ELISPOT assays confirmed the reciprocal patterns of IFN-gamma or IL-4 production by T cells in similar frequencies in the respective groups of mice, and antibody analysis confirmed the presence of Th2-mediated isotype switching in the knockout mice. These data suggest that CD4+ T cells that normally respond to antigens by differentiation to Th1 cells default to the Th2 pathway in the absence of endogenous IFN-gamma.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Immunol. 1987 Jun 15;138(12):4496-501 - PubMed
    1. J Exp Med. 1993 Oct 1;178(4):1435-40 - PubMed
    1. J Immunol. 1989 Feb 15;142(4):1293-8 - PubMed
    1. Annu Rev Immunol. 1989;7:145-73 - PubMed
    1. J Immunol. 1989 Jul 1;143(1):266-74 - PubMed

Publication types